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ABSTRACT 
The process of myogenesis within skeletal muscle (SKM) is essential for growth and repair and is 
coordinated via the expression of myogenic regulatory genes. Previous animal studies have reported that 
formoterol, a beta-adrenergic receptor agonist, has stimulating effects on genes related to SKM 
mitochondrial function and biogenesis, similar to effects found for exercise. Lesser known is the potential 
“exercise mimetic” influence that formoterol stimulation may have during the stages of myogenesis, 
especially in human SKM cells.  PURPOSE: To investigate the effects of formoterol stimulation on 
expression of myogenic regulatory genes during myogenesis in human SKM cells. METHODS: Human 
SKM myoblasts (n = 6 per group) were cultured and differentiated until mature myotube formation (Day 
6). Groups included control cells (CON) and cells stimulated by 30nM formoterol for 3h prior to RNA 
extraction points (FORM). Total RNA was extracted during mid-myogenesis (Day 4) and at terminal 
differentiation (Day 6) (a cell culture model of investigating myogenesis). Gene expression for Myogenic 
factor 5 (Myf5), Myogenic differentiation 1(MyoD), and Myogenin (MyoG) was determined by qPCR. Data 
was analyzed using repeated measures ANOVA. RESULTS: Myf5: There was no change for either 
condition for D4. D6 CON was lower than D4 CON (-0.25). D6 FORM was greater than D4 FORM (0.65) 
and D6 CON (0.75). MyoD: D4 FORM was lower than D4 CON (-0.57). D6 FORM was greater than D4 
FORM (0.85) and lower than D6 CON (-0.16). D6 CON was lower than D4 CON (-0.33). MyoG: D4 FORM 
was lower than D4 CON (-0.72). D6 CON was lower than D4 CON (-0.44). D6 FORM was lower than D6 
CON (-0.24). All reported differences are significant (p < 0.05). Data are expressed as fold changes. 
CONCLUSION: As expected, for the CON group, Myf5, MyoD, and MyoG expression all decreased from 
D4 mid-myogenesis to D6 terminal myogenesis, indicating finalization of the myogenic gene program. For 
the FORM group, Myf5 expression was elevated at D6 compared to CON while MyoG and MyoD 
expression was lower than CON for D4 and D6. The interpretation is that FORM stimulation increased 
stimulus of D4 myoblast proliferation and, thus, delayed initiation of differentiation. These results, 
coupled with other preliminary data from our lab showing increased mitochondrial biogenesis with this 
model of investigation, suggests that this exercise mimetic stimulation may cause shift in the cell towards 
bioenergetic preference rather than fusion of myotubes.   
 
